Literature DB >> 16990487

Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease.

Julie Perucca1, Nadine Bouby, Pierre Valeix, Lise Bankir.   

Abstract

Men are known to be at greater risk of urolithiasis and cardiovascular and renal diseases than women. Previous studies suggest that greater urine concentration is associated with acceleration of progression of chronic kidney disease (CKD), increased urinary albumin excretion, and delayed renal sodium excretion. The present review addresses possible sex-related differences in urine volume and osmolality (U(osm)) that could participate in this male risk predominance. Because of the scarcity of information, we reanalyzed 24-h urine data collected previously by different investigators for other purposes. In nine studies concerning healthy subjects (6 studies) or patients with CKD or diabetes mellitus, U(osm) (or another index of urine concentration based on the urine/plasma creatinine concentration ratio) was 21-39% higher (i.e., about a 150 mosm/kgH2O difference) in men than in women. Urine volume was not statistically different. Thus, the larger osmolar load of men (related to their higher food intake) is excreted in a more concentrated urine with no difference in urine volume. This sex difference was not influenced by the level of sodium excretion and was still present in CKD patients. Sex differences in thirst threshold, AVP level, and other regulatory mediators may all contribute to the higher male U(osm). Because of the previously demonstrated adverse effects of vasopressin and/or high urine concentrating activity, the greater tendency of men to concentrate urine could participate in their greater susceptibility to urolithiasis and hypertension and to the faster progression towards end-stage renal failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990487     DOI: 10.1152/ajpregu.00500.2006

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  41 in total

1.  Water prescription in autosomal dominant polycystic kidney disease: a pilot study.

Authors:  Connie J Wang; Catherine Creed; Franz T Winklhofer; Jared J Grantham
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

Review 2.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

Review 3.  Mammalian urine concentration: a review of renal medullary architecture and membrane transporters.

Authors:  C Michele Nawata; Thomas L Pannabecker
Journal:  J Comp Physiol B       Date:  2018-05-24       Impact factor: 2.200

Review 4.  Vasopressin: a novel target for the prevention and retardation of kidney disease?

Authors:  Lise Bankir; Nadine Bouby; Eberhard Ritz
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

5.  High salt intake reprioritizes osmolyte and energy metabolism for body fluid conservation.

Authors:  Kento Kitada; Steffen Daub; Yahua Zhang; Janet D Klein; Daisuke Nakano; Tetyana Pedchenko; Louise Lantier; Lauren M LaRocque; Adriana Marton; Patrick Neubert; Agnes Schröder; Natalia Rakova; Jonathan Jantsch; Anna E Dikalova; Sergey I Dikalov; David G Harrison; Dominik N Müller; Akira Nishiyama; Manfred Rauh; Raymond C Harris; Friedrich C Luft; David H Wassermann; Jeff M Sands; Jens Titze
Journal:  J Clin Invest       Date:  2017-04-17       Impact factor: 14.808

6.  Influence of age and sex on signal intensities of the posterior lobe of the pituitary gland on T1-weighted images from 3 T MRI.

Authors:  Asako Yamamoto; Hiroshi Oba; Shigeru Furui
Journal:  Jpn J Radiol       Date:  2012-12-26       Impact factor: 2.374

7.  Quantitative identification of and exposure to synthetic phenolic antioxidants, including butylated hydroxytoluene, in urine.

Authors:  Wei Wang; Kurunthachalam Kannan
Journal:  Environ Int       Date:  2019-04-25       Impact factor: 9.621

8.  Presence of the posterior pituitary bright spot sign on MRI in the general population: a comparison between 1.5 and 3T MRI and between 2D-T1 spin-echo- and 3D-T1 gradient-echo sequences.

Authors:  Verena Klyn; Sven Dekeyzer; Ruth Van Eetvelde; Pieter Roels; Ortwin Vergauwen; Pieter Devolder; Martin Wiesmann; Eric Achten; Omid Nikoubashman
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

Review 9.  Hyperosmolarity drives hypertension and CKD--water and salt revisited.

Authors:  Richard J Johnson; Bernardo Rodriguez-Iturbe; Carlos Roncal-Jimenez; Miguel A Lanaspa; Takuji Ishimoto; Takahiko Nakagawa; Ricardo Correa-Rotter; Catharina Wesseling; Lise Bankir; Laura G Sanchez-Lozada
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

10.  Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.

Authors:  Fang Zhao; Eric J Bergstralh; Ramila A Mehta; Lisa E Vaughan; Julie B Olson; Barbara M Seide; Alicia M Meek; Andrea G Cogal; John C Lieske; Dawn S Milliner
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-10       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.